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TreeDT: Tree Pattern Mining for Gene Mapping
Petteri Sevon, Hannu Toivonen, and Vesa Ollikainen
Abstract—We describe TreeDT, a novel association-based gene mapping method. Given a set of disease-associated haplotypes and
a set of control haplotypes, TreeDT predicts likely locations of a disease susceptibility gene. TreeDT extracts, essentially in the form of
haplotype trees, information about historical recombinations in the population: A haplotype tree constructed at a given chromosomal
location is an estimate of the genealogy of the haplotypes. TreeDT constructs these trees for all locations on the given haplotypes and
performs a novel disequilibrium test on each tree: Is there a small set of subtrees with relatively high proportions of disease-associated
chromosomes, suggesting shared genetic history for those and a likely disease gene location? We give a detailed description of
TreeDT and the tree disequilibrium tests, we analyze the algorithm formally, and we evaluate its performance experimentally on both
simulated and real data sets. Experimental results demonstrate that TreeDT has high accuracy on difficult mapping tasks and
comparisons to other methods (EATDT, HPM, TDT) show that TreeDT is very competitive.
Index Terms—Biology and genetics, nonparametric statistics, nonnumerical algorithms and problems.

1 INTRODUCTION
THE discovery of new disease susceptibility genes canhave immense importance for human health care. The
gene and the proteins it produces can be analyzed to
understand the disease-causing mechanisms and to design
new medicines. Further, gene tests on patients can be used
to assess individual risks and for preventive and individu-
ally tailored medications.
Gene mapping aims at discovering areas in the genome
that have a statistical connection to a given trait. In
association studies, genetic markers and haplotypes along
chromosomes are used to discover associations between
phenotypes (e.g., diseased-associated versus control) and
chromosomal regions (i.e., potential disease gene loci) in
samples of haplotypes from patients and control indivi-
duals. The growing number of available markers, hundreds
of thousands now being available on off-the-shelf chips,
opens new opportunities, but also emphasizes the impor-
tance of computationally scalable methods.
We introduce TreeDT, a novel method for gene mapping.
It analyzes the observed haplotypes by constructing
haplotype trees, tree-structured string patterns that reflect
the genetic history of potential disease susceptibility (DS)
gene loci. Roughly, the idea is as follows: At a specific locus,
TreeDT uses haplotype trees as estimates for the genealogy
of the sample of haplotypes. In the genealogy at (or near) a
true DS gene locus, disease-associated chromosomes are
overrepresented in one or more subtrees in which all
chromosomes have inherited the disease predisposing
mutation from a common ancestor. We call this phenom-
enon tree disequilibrium. At locations far from the DS locus,
the genealogical trees are expected to be in equilibrium. The
TreeDT method estimates and tests the disequilibrium of
genealogical trees at a number of loci and predicts a DS
gene to be where the most significant disequilibrium is
observed. The idea of TreeDT mapping was preliminarily
reported in reference [1].
The contributions of TreeDT are the following:
1. a novel approach to gene mapping using the analogy
between the concepts of genealogical trees and
haplotype trees,
2. specification of a statistical test for assessing tree
disequilibrium at a given location, for comparing the
results across several loci, and for estimating the
overall statistical significance of the best finding, and
3. an efficient algorithm for the tests, including an
algorithm for carrying out multiple nested permuta-
tion tests at the cost of a single permutation test.
In the next section, we review the gene mapping
problem. In the following sections, we specify the proposed
method and then give an algorithm for it. After a brief
review of related work, we experimentally evaluate and
compare the performance of the algorithm. Finally, we
conclude with a discussion.
2 PROBLEM BACKGROUND
Let us assume the goal is to locate a disease-susceptibility
gene for a given disease. We next briefly review the genetic
background; without loss of generality, we restrict the
discussion in this paper to one chromosome. In case one has
several chromosomes to analyze, the results for different
chromosomes are independent and Bonferroni correction
[2] can be applied to the p values obtained by TreeDT for
individual chromosomes.
A genetic marker is a short polymorphic region in the
DNA, denoted here by M1, M2, .... The different sequence
variants (alleles) at the marker locus are denoted in our
examples by positive integers. The number of alleles per
marker is small: typically, less than 10 (for microsatellite
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markers) or exactly two (for SNP markers). The collection of
markers used in a particular study constitutes its marker map
and the corresponding alleles in a given chromosome
constitute its haplotype. For the purposes of this paper, the
input data consists of haplotypes of diseased and control
individuals.
All of the current carriers of a disease predisposing
mutation have inherited it from one or more ancestral
chromosomes that have introduced it into the population.
They also have inherited segments of varying length
around the mutation (Fig. 1). With sufficiently dense
marker maps, it is possible to observe linkage disequilibrium
(LD), nonrandom association between nearby markers. Due
to sharing of segments inherited from a common mutation-
carrying ancestral chromosome, there is also LD between
the unobserved DS gene and markers near it and,
consequently, the markers can be used as surrogates for
the DS gene in genetic analyses.
In diseases with a reasonable genetic contribution and
especially in population isolates into which a few founders
have introduced the mutation, affected individuals are
likely to have higher frequencies of alleles and haplotype
patterns inherited from a common ancestor (e.g., a founder
of a population isolate) near the DS gene locus than control
individuals. This is the starting point of association-based
mapping methods: Where in the genome are haplotype
patterns strongly associated to the disease? While the
principle is simple, the problem is far from trivial. The
recombination history is stochastic; mutation carriers often
only have a higher risk of being diseased than noncarriers
and, in a case-control study, both groups are usually mixes
of carriers and noncarriers; finally, there is missing
information.
Our gene mapping framework belongs to the family of
association/LD-based mapping methods. It is applicable to
case-control settings, where the input consists of disease-
associated and control haplotypes. Each individual con-
tributes a chromosome pair, so the number of chromosomes
is twice the number of individuals. We ignore the fact that
chromosomes come in pairs and simply consider the input
data as consisting of a set of independent haplotypes. The
task is now to predict the location of a disease susceptibility
gene on the map, given a set of disease-associated
haplotypes and a set of control haplotypes.
3 METHOD
3.1 Haplotype Trees
TreeDT is based on estimating and evaluating the geneal-
ogy of the observed haplotypes. At any given location, the
(unknown) genealogical tree consists of the chromosomes in
the sample as the leaves and each internal node corre-
sponds to the most recent common ancestor (MRCA) chromo-
some of its descendants in the tree. Due to recombinations,
different parts of a chromosome have different histories and
genealogical trees vary across the chromosome.
In the genealogical tree for a DS gene locus, all the
chromosomes in one or more subtrees—depending on how
many times the mutation has been introduced to the
population (sample)—have inherited the disease predis-
posing mutation. These subtrees should then have more
disease-associated chromosomes than other parts of the
tree. In the genealogical tree for a random locus, in contrast,
disease-associated and control chromosomes are randomly
distributed. Since the expected number of historical
recombination events between two locations increases with
the distance between them, the closer a location is to the
DS gene, the more similar its genealogical tree is to the
genealogy of the DS gene.
True genealogies are not known, but haplotypes can be
used to estimate them. Given a location in the chromo-
some—a potential DS gene locus—the haplotypes to the
right of the location can be organized into a tree by their
shared prefixes (Fig. 2 and Fig. 3), as can haplotypes to the
left. TreeDT uses the right and left trees as two different
estimates of the genealogical tree at the location. At a given
locus, a pair of chromosomes shares a region, inherited
from their MRCA, around the locus. Inside this region, no
crossovers have occurred in either of the lineages descend-
ing from the MRCA to the two chromosomes. The more
distant the MRCA, the more recombination events have
taken place in the two lineages and, consequently, the
shorter the expected length of the shared region is. The use
of haplotype trees to estimate genealogies is based on the
converse of the observation above: The expected time to the
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Fig. 1. A carrier of the mutation in generation 20 has inherited alleles
from the ancestral chromosome in generation 0 around the gene locus.
Fig. 2. Set of haplotypes A-F, sorted by the partial haplotypes to the right
from the location pointed to by the arrow.
MRCA of a pair of haplotypes decreases as the length of
haplotype sharing between them increases. The structure of
a haplotype tree perfectly complies with this observation
and, in this sense, it gives the most likely genealogy. The
most typical error is a wrong order for internal nodes, but
this often has a small effect or no effect at all on the accuracy
of TreeDT (Fig. 3).
3.2 Tree Disequilibrium Test
TreeDT constructs the left and right haplotype trees
between each pair of consecutive markers. For each tree, it
then assesses tree disequilibrium: Are disease-associated
haplotypes overrepresented in a set of subtrees, suggesting
that the tree has been constructed at or near a DS locus? Our
test considers all different cardinalities of subtree sets
(denoted by k throughout the text) up to the number of
haplotypes in the data set, or possibly limited by some
maximum value kmax.
We introduce a novel tree disequilibrium test, intended
for predicting DS gene locations. The vicinity of the location
for which the test gives the lowest p value (the most
significant disequilibrium) is the most likely candidate area
for the DS gene location. The method also computes a
corrected overall p value for the most significantly disease-
associated location, which can be used for predicting
whether there is a DS gene in the studied chromosome at
all or not.
The tests performed by TreeDT are organized in a four-
level hierarchy. All the tests are conditional on the
estimated genealogical trees and only test the distribution
of the disease-association statuses of the haplotypes in the
trees. The null hypotheses effectively state that there is no
genetic effect in the observed data, i.e., the disease-
association statuses are randomly assigned to the observed
haplotypes.
We first give an overview of the testing hierarchy and
then describe each level in more detail, including defini-
tions of the null hypotheses and test statistics. The levels of
the hierarchy are, in bottom-up order:
0. For a fixed set S of nonoverlapping subtrees of a
haplotype tree, we define statistic ZkðSÞ (1), k ¼ jSj,
corresponding to null hypothesis H0ðSÞ, to be used
as a measure of disequilibrium. No p values are
estimated at this level.
1. For each haplotype tree T in the set of left and right-
side haplotype trees at all tested locations and each
number of subtrees k, TreeDT computes test statistic
ZMAXkðT Þ (2), the maximum of ZkðSÞ over all sets
S of k nonoverlapping subtrees of T , and estimates
the respective p value pkðT Þ under null hypothesis
H1ðT; kÞ.
2. For each tested location l, TreeDT estimates a local
p value local pðlÞ using a test statistic derived from
pkðTLÞ and pkðTRÞ for all k, where TL and TR are the
left and right-side haplotype trees at location l
(statistic dðlÞ given in (3); null hypothesis H2ðlÞ).
3. At the top level, TreeDT estimates an overall p value
overall p. It is corrected for multiple testing over
tested locations using the smallest local p value as
the test statistic (null hypothesis H3).
3.2.1 Level 0: Measuring Disequilibrium of a Given Set
of Subtrees
At the bottom level of the testing hierarchy, we consider
null hypothesis H0ðSÞ for assessing the disequilibrium of a
fixed set S of subtrees of a given haplotype tree.
Null hypothesis H0ðSÞ. Haplotypes in set S are not
disease-associated at a higher probability than haplotypes
in the entire data.
For measuring the disequilibrium, we define an ad hoc
Zk statistic, which is a sum of k standard Z statistics. For a
set S of k nonoverlapping subtrees T1; . . . ; Tk,
ZkðSÞ ¼
Xk
i¼1
zi;
where zi ¼
ainipﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
nipð1pÞ
p ; if ni > 1
0; if ni ¼ 1;
( ð1Þ
where ai is the number of disease-associated haplotypes
and ni the total number of haplotypes in subtree Ti 2 S, and
p is the proportion of disease-associated haplotypes in the
whole sample. Each zi measures the departure of the
observed number of disease-associated chromosomes (ai)
from the expectation (nip) in standard deviations
(
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
nipð1 pÞ
p
) in subtree Ti under the assumption of
binomial distribution with parameters ni and p and is
approximately normal if ni is large. Subtrees consisting of a
single leaf do not contribute to the test statistic since it is
only possible to extract localization information from two or
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Fig. 3. On the left, the true (unobserved) genealogy for the haplotypes at the pointed location in Fig. 2. On the right, the haplotype tree used as an
estimate of the true genealogy. The disease-associated haplotypes are underlined. In this example, the tree is constructed at the DS gene locus and
the mutation-carrying haplotypes form a single subtree {D, E, F}, even though the order of internal nodes of subtree {D, E, F} is incorrectly estimated.
more haplotypes sharing a region. We are interested only in
subtrees in which the proportion of disease-associated
haplotypes is greater than expected, zi > 0 (i.e., we assume
the mutation to increase the risk of the disease).
3.2.2 Level 1: Estimation of a p Value for a Given
Haplotype Tree and Number of Subtrees
We do not test against H0ðSÞ directly for sets S of
nonoverlapping subtrees of a given tree T . Instead, we
perform a single test for each k (number of subtrees) against
null hypothesis H1ðT; kÞ.
Null hypothesis H1ðT ; kÞ. There is no set of k non-
overlapping subtrees of T in which haplotypes are disease-
associated at a higher probability than haplotypes in the
entire data.
As the test statistic for given T and k, we use the
maximum value of Zk over all sets of k nonoverlapping
subtrees of T , denoted by ZMAXkðT Þ:
ZMAXkðT Þ ¼
maxfZkðSÞjS is a set of k nonoverlapping subtrees of Tg:
ð2Þ
We chose Zk as the base statistic because it can be
efficiently maximized in the space of all possible subtree
sets simultaneously for all k, using the recursive algorithm
given in the Algorithms section. Efficiency of the max-
imization procedure is important because it is performed
many times, often millions, during the execution of TreeDT.
Given a tree T , the ZMAXkðT Þ statistic has different
distributions for different numbers k of subtrees. In order to
get a comparable measure for all values of k, TreeDT
estimates a p value pkðT Þ for each k under null hypothesis
H1ðT; kÞ using a permutation test, as will be described later.
We are aware that the maximization of the test statistic
introduces a selection bias favoring smaller subtrees, but, at
this point, we have not taken any actions to compensate for it.
3.2.3 Level 2: Estimation of Local p Values
In order to get a single p value representing the disequili-
brium at location l, we need to combine the information
from the trees to the left and to the right of the location. As a
combined measure, we use dðlÞ, the product of the lowest
p values over all k from each side:
dðlÞ ¼ min
k
fpkðTLðlÞÞg min
k
fpkðTRðlÞÞg; ð3Þ
where TLðlÞ and TRðlÞ are the left and right haplotype trees
at location l. Since the values of dðlÞ are not directly
comparable across the chromosome, e.g., due to varying
marker density and background LD, a new local p value,
local pðlÞ, for the combination is estimated under null
hypothesis H2ðlÞ. The local p values are comparable across
different loci.
Null hypothesis H2ðlÞ. There is no set of (at most kmax)
nonoverlapping subtrees in the haplotype tree for either
side of location l in which haplotypes are disease-associated
at a higher probability than haplotypes in the entire data,
i.e., there is no gene effect present at location l.
The output of TreeDT is essentially a list of p values for
the tested locations. A point prediction for the gene location
is obtained by taking the best location; alternatively, a
(potentially fragmented) region of length x is obtained by
taking the best locations until a length of x is covered. A
direct link between the p value and the probability that the
gene is indeed close to the location cannot be established.
The local p values are used simply as a method of ranking
the locations.
3.2.4 Level 3: Estimation of a Corrected Overall p Value
A single corrected p value for the best finding can be
obtained with a third significance test using the lowest local
p value as the test statistic (H3).
Complete null hypothesisH3: There is no set of (at most
kmax) nonoverlapping subtrees in the haplotype tree for
either side of any tested location in which haplotypes are
disease-associated at a higher probability than haplotypes
in the entire data, i.e., there is no genetic effect present in the
entire data.
The resulting overall p value can be used to answer the
question whether there is a gene in the investigated area in
the first place or not: The null hypothesis is rejected if the
resulting p value is lower than a predetermined significance
level.
Since there are dependencies among tests at levels 0-2,
the null distributions of test statistics at levels 1-3 are very
complex (due to maximization and minimization), regard-
less of how we define the null distribution at level 0. We
therefore resort to resampling techniques (see, e.g., [3]) to
estimate the joint null distributions of the test statistics and,
consequently, the p values. Ignoring mutual dependencies
and using, e.g., Bonferroni correction to obtain the overall
p value would result in grossly inflated p values.
The complete null hypothesis effectively states that the
disease-association statuses are randomly assigned to the
haplotypes. In a typical study setting, the numbers of
disease-associated and control haplotypes in the sample are
predetermined and, therefore, random permutation of
disease-association statuses of the haplotypes is the appro-
priate resampling method. A permutation test is conducted
in the following way: 1) Draw a sample of resampled data
sets, where the disease-association statuses of the haplo-
types are randomly permuted, 2) compute the appropriate
test statistic for each data set in the sample, and 3) estimate
a p value by comparing the test statistic for the observed
data to the empirical null distribution obtained from the
permuted data sets.
Because null hypotheses H2ðlÞ, H1ðT; kÞ, and H0ðSÞ are
restrictions of H3 to location l, haplotype tree T and number
k of subtrees, and set S of subtrees, respectively, tests
against all null hypotheses H0-H3 can be carried out as
permutation tests as described above.
4 ALGORITHMS
The TreeDT algorithm can be decomposed into two
subtasks: 1) construction of the left and right-side haplotype
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trees for each location and 2) carrying out the permutation
tests. These tasks are discussed in detail in the following
subsections.
4.1 Constructing Haplotype Trees
The haplotype trees to the left and right from each analyzed
location can be efficiently constructed using the textbook
radix sort algorithm (see, e.g., [4]). The algorithm iterates
over all markers from right to left. At each marker, the
intermediate result is a sorted list of the partial haplotypes
to the right from the marker. A right-side tree can be easily
derived from the intermediate list because the haplotypes
belonging to one node form a continuous block in the sorted
list (see Fig. 2 and Fig. 3 for an example). The left-side trees
can be identified similarly by sorting the inverted haplo-
types. The computational cost of constructing all the trees is
linear both in the number of markers and the number of
haplotypes and it is negligible compared to the cost of the
permutation test procedure.
4.2 An Algorithm for Maximizing the Zk Test
Statistic
The first stepof the testingprocedure is computationof level 1
test statistic ZMAXk for all haplotype trees T and numbers k
of subtrees; level 0 is completely embedded in this step. It is
essential that the time complexity of the algorithm for
maximizing the Zk values is as low as possible because it
must be executed for each haplotype tree and permutation in
turn. An efficient recursive algorithm, MaximizeZ, which
propagates the locally maximized Zk values upwards in the
haplotype tree, is presented in Fig. 4.
Let us generalize ZMAXk to apply to forests (sets of
trees) in the obvious way: ZMAXkðF Þ is the maximum
value of ZkðSÞ, where S is a set of k nonoverlapping
subtrees of forest F . The algorithm is based on the recursive
definition of ZMAXk:
ZMAXkðfT1; . . . ; TmgÞ ¼
max
Uf1;...;mg
X
i2U
ZMAXkiðTiÞ
X
i2U
ki ¼ k

( )
ZMAXkðT Þ ¼
ZMAXkðISðT ÞÞ; if k > 1
max Z1ðfTgÞ; ZMAX1ðISðT ÞÞf g; if k ¼ 1;

where ISðT Þ is the set of immediate subtrees of T (subtrees
whose roots are children of the root of tree T ).
For haplotype tree T that is not a leaf, the algorithm first
computes ZMAXk statistics for the forest F consisting of all
its immediate subtrees. The subtrees are processed one at a
time: For each subtree, the algorithm first recursively calls
itself and then computes ZMAXk statistics for the forest of
all the previously processed subtrees and current subtree
(lines 6-14). The ZMAXk values of tree T are identical to
those of forest F , except for k ¼ 1, where it is the maximum
of Z1ðT Þ and ZMAX1ðF Þ (lines 15-17).
The time complexity of the algorithm is Oðn2Þ, both on
average and in the worst case, where n is the number of
leaves in the tree, i.e., the number of haplotypes in the data
set. By setting an upper limit kmax for the size of the subtree
sets, the time complexity can be reduced to OðnÞ with a
constant coefficient proportional to k2max, kmax being typi-
cally small,  10. The only modification required in the
algorithm is an additional condition  kmax for index k and
sum iþ j at lines 6, 8, 10, 13, and 15 of the algorithm. When
LD-mapping is applicable, the majority of mutation carriers
are concentrated in only a few subtrees of the haplotype
trees at the DS gene locus and using this prior information
to restrict the number of subtrees may slightly increase the
power of the method, as shown in the Experiments section.
In the experiments for this paper, we use an upper limit of
three subtrees.
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Fig. 4. Algorithm for calculating ZMAXkðT Þ for all values of k.
The space complexity is OðnÞ if the number of subtrees is
not restricted. The average complexity reduces to OðlognÞ
for the restricted case. Proofs for the correctness and time
and space complexities of the algorithm are given in
Appendix A, which can be found on the Computer Society
Digital Library at http://computer.org/tcbb/archives.htm.
4.3 An Efficient Algorithm for Multiple Nested
Permutation Tests
With permutation tests, p values are estimated by compar-
ing the test statistic to a sample drawn from its null
distribution obtained by randomly permuting the observed
data set. The proportion of permutations for which the test
statistic has at least as extreme a value as the observed value
is an unbiased estimate for the p value:
p ¼ 1
q
i 2 1; . . . ; qf g si  sojf gj j; ð4Þ
where so is the observed value of the statistic, si is the value of
the statistic from the ith random permutation, and q is the
number of permutations. If the test statistic is being
minimized instead of maximized, as is the case with
p values as test statistics, then si  so should be replaced
with si  so.
With nested permutation tests, the upper level test
statistics are based on p values from the lower level tests.
In order to draw a sample from the null distribution at the
upper level, these lower level p values must also be
computed for permuted data sets by sampling repermuted
data sets from each original permuted set. The straightfor-
ward algorithm for a two-level nested permutation test
using nested loops would have time complexity propor-
tional to q2, where q is the number of permutations at each
level, as for each of the q permutations at the top-level,
q permutations are generated at the bottom-level.
With TreeDT, there are three levels of nested permuta-
tion tests (levels 1-3, no p values were estimated at level 0)
and the time complexity of the simple algorithm is
proportional to q3. The test would be intractable already
with rather low permutation counts. However, the time
complexity can be drastically reduced using the same set of
permutations at each level of the test and comparing each
permutation to all other permutations and the unpermuted
data, thus only maximizing the Zk values q times instead of
q3 times for each haplotype tree. This is possible because
any random permutation of a permuted data set is also a
random permutation of the original data. The improved
algorithm, NestedPermutationTests, is presented in Fig. 5.
The problem with computing p values for a permuted
data set is that there are only q  1 other random
permutations to compare to, resulting in different granula-
rities of p values for the permutations and the observed
data. There are two possible solutions: either generate an
extra permutation or include the observed data in the
comparison. We chose the latter approach because it
guarantees consistency of p values: If the observed value
of the test statistic is more extreme than the value for a
permuted data set, then the p value for the observed data set
is guaranteed to be smaller than the p value for the
permuted data set. This would not be the case if an extra
permutation was generated for comparison.
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Fig. 5. Algorithm for nested permutation tests.
If a null hypothesis is not true, then the observed data is
not drawn from the null distribution and the respective
p values for permuted data sets that are larger than the
p value for the observed data are conservative (by less than
1=q). This may result in slightly anticonservative local and
overall p values for the observed data; however, this only
happens if the null hypothesis should be rejected and, thus,
does not affect the Type I error rate, but may increase
statistical power.
Due to the finite number of permutations, the precision of
the p values given by a permutation test may not be sufficient
for accurate localization. In some situations, even a very large
number of permutations do not produce any values for the
test statistic as extreme as the observed values for several
consecutive locations. For this reason, the p values returned
by the first and second level permutation tests aredetermined
slightly unconventionally. At levels 1 (line 8) and 2 (line 13),
the returned p value is interpolated linearly between the p
values corresponding to the next lower and higher values for
the test statistic obtained by permutations. At level 1, if the
observed value so of the ZMAXk statistic is higher than the
highest value sp obtained from the permutations, the p value
is extrapolated using the ratio of the two scores,
p ¼ spqso  1q . At level 2, if the observed value of the d statistic
is lower than the lowest obtained from the permutations, a
lower boundary value of zero for d is used to interpolate the
p value. Finally, the top-level test returning the overall p
value is implemented in the usual conservative manner (4).
The time complexity of the loops at lines 7 and 12 is
Oðq log qÞ using an algorithm which first sorts the values of
the test statistic for all the permutations. The time complex-
ity of the algorithm, predominated by calls to MaximizeZ, is
Oðqn2sÞ (or OðqnsÞ if an upper limit kmax is given), where n2
(or n) is the time complexity of the MaximizeZ algorithm
and s is the number of markers (or tested locations) in the
chromosome.
4.4 Algorithm TreeDT
As a summary, we give an informal description of the
TreeDT algorithm. As input it takes a marker map and a set
of disease-associated and control haplotypes. The para-
meters for the algorithm are the number of permutations
and, optionally, the maximum or exact number of subtrees
to be tested. Its output consists of local p values for all tested
locations and an overall corrected p value as returned from
the NestedPermutationTests algorithm. The set of locations
to be tested is the set of intervals between adjacent markers
and the flanking regions on both sides of the marker map.
The haplotypes are sorted using the radix sort algorithm.
Construction of haplotype trees and level 1 of Nested
PermutationTests are interleaved: After each iteration of
radix sort, level 1 of the permutation procedure is
performed for the right-side haplotype tree implicit in the
intermediate sorting result. One only needs to store the
smallest p value over all numbers of subtrees for each
haplotype tree and each permutation. In a second pass, the
same is done for the inverted haplotypes and the left-side
haplotype trees. All there is left after this point is
straightforward execution of levels 2 and 3 of the permuta-
tion algorithm.
5 RELATED WORK
During the past decade, several parametric statistical gene
mapping methods have been proposed that model LD
around the DS gene [5], [6], [7], [8], [9], [10]. Some more
recent methods explicitly model the genealogy of the
sample at the DS locus [11], [12], [13]. These methods
typically estimate a number of parameters, most impor-
tantly, the location of the DS gene and the respective
confidence intervals. However, the models are based on a
number of assumptions about the inheritance model of the
disease and the structure of the population, which may be
misleading for the statistical inference. The methods tend to
be computationally complex, especially with respect to the
number of markers.
TreeDT belongs to the class of nonparametric gene
mapping methods, which typically scale well to very large
data sets. The simplest nonparametric test for case-control
haplotype data tests all haplotypes of adjacent markers up
to some maximum length for disease association using, e.g.,
Fisher’s exact test or the 2-test for independence.
Transmission/disequilibrium tests (TDT) [14] are an
established way of testing whether alleles or haplotypes
are transmitted from heterozygous parents to affected
offspring more often than expected. We performed multi-
point TDT analyses with microsatellite data using the
GENEHUNTER2 software package [15]. With SNP data, we
used the Exhaustive Allelic TDT (EATDT) of Lin et al. [16],
which performs the TDT test for all haplotypes up to a
given maximum length.
Haplotype Pattern Mining (HPM) [17] analyzes the
disease association of each marker based on the set of
haplotype patterns, essentially strings with wildcard char-
acters, overlapping it. HPM has been extended for detecting
multiple genes simultaneously [18] and to handle quantita-
tive phenotypes and covariates [19]. Extending HPM to
analyze unphased genotypes instead of haplotypes and to
computeoverall corrected pvalueshasbeendiscussed in [20].
Recently, methods have been proposed that explicitly
account for allelic heterogeneity at theDS gene [21], [22], [23].
An alternative approach for LD-based mapping is
linkage analysis. The idea is to analyze families and to find
out at which markers alleles tend to be co-inherited with the
disease. Linkage analysis does not rely on linkage dis-
equilibrium, so, in that respect, it is more widely applicable
than LD-based methods. The downside is that estimates are
rough (due to the smaller effective number of meioses
utilized), that it has weaker power to detect genes with
moderate effect, and that collecting information from larger
families is more difficult and expensive.
The nested permutation test procedure in TreeDT is
closely related to the maxT (level 1) and minP (levels 2 and
3) methods by Westfall and Young [3], intended for
adjusting p values for multiple simultaneous tests. For
example, the overall p value returned by TreeDT is the same
as the most significant local p value adjusted using the minP
method. However, Westfall and Young did not give a
computationally efficient algorithm for the method nor did
they consider more deeply nested tests than two-level
permutation. Ge et al. [24] have independently proposed a
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fast algorithm for two-level permutation testing that, like
TreeDT, uses the same set of permutations on both levels.
6 EXPERIMENTS
We next empirically evaluate the performance of TreeDT
and compare it to other methods suitable for the analysis of
very large data sets: single marker TDT, multipoint TDT of
GENEHUNTER2 (hereafter m-TDT for short) using haplo-
types of up to four markers, EATDT, and HPM, our earlier
proposal based on haplotype patterns. We evaluate the
methods on simulated microsatellite and SNP data and a
real Type 1 diabetes data set.
6.1 Data Sets
6.1.1 Simulated Data
We designed several different test settings, with variation in
the strength of the genetic effect, in the number of founders
who introduced the mutation to the population, in the
amount of missing information, and in the sample size. One
set of fixed values for these parameters will be used as a
baseline setting, against which the effects of the parameters
will be compared. For statistical analyses, we created
100 independent artificial data sets in each test setting.
Great care was taken to generate realistic data; a detailed
description of the simulation procedure is given in
Appendix B, which can be found on the Computer Society
Digital Library at http://computer.org/tcbb/archives.htm.
We simulated an isolated population that had grown
from 100 founders to 100,000 individuals over a period of
20 generations. A fixed number of sources (founder
chromosomes) of the mutation were selected for each data
set. In the baseline setting, there is one mutation-carrying
founder chromosome with 2 percent frequency in the final
population.
Our disease model was fully penetrant; all the mutation
carriers were affected. We selected a challenging disease
model where only a small proportion A (in the baseline
setting A ¼ 10%) of the disease-associated chromosomes
carries the disease-predisposing mutation, a complication
often encountered in the analysis of common diseases.
For each data set, we sampled random affected indivi-
duals (100 in the baseline setting) from the final generation
and their parents. For each individual in the sample, the
simulation produced an unordered allele pair (genotype) for
101 microsatellite markers spaced equidistantly over a
100 cM chromosome. By looking at the genotypes of the
offspring-parents-trio, we can infer which alleles have been
transmitted to the offspring. The haplotypes constructed
from the alleles transmitted to each affected individual in a
sample were labeled disease-associated, whereas the
haplotypes constructed from the nontransmitted alleles of
the parents can be conveniently used as controls. However,
in a rare case of three similar heterozygote genotypes at a
marker (both parents and the offspring), the parental origin
of the inherited alleles is ambiguous. We chose to take this
into account by setting the alleles unknown in these cases.
Thus, 3.7 percent of alleles are missing, making the
mapping task more difficult, but also more realistic. The
final output of the simulation procedure is a collection of
100 data sets, consisting of 200 disease-associated and
200 control haplotypes in our baseline setting.
We also included one setting with dense SNP data from a
general population with no recent founder effect. We used
data provided by Lin et al., simulated for the original
EATDT article [16]. There were 50 data sets, each consisting
of a 5 Mb (= 5 cM) sequence simulated using an improved
version of Hudson’s algorithm for coalescent model with
recombination [25]. The number of markers varied from 504
to 571 and the average D’ between adjacent markers was
~0.76. The frequency of the disease predisposing mutation
was 0.1. The risk of becoming affected was three times
larger for mutation carriers (nine times larger for double
carriers) than noncarriers and prevalence was 3.3 percent.
For our experiments, we sampled 100 trios from the original
data sets with about 450 nuclear families. With these data,
we compared TreeDT to EATDT, which infers haplotypes
with no missing alleles from trios using a method by the
same authors [26]. We used the haplotypes inferred by
EATDT also as input for TreeDT and HPM.
6.1.2 Real Type 1 Diabetes Data
In order to test and demonstrate the real-life performance of
TreeDT,we analyzed a Type 1 diabetes data set [27].We have
used exactly the same data set in the article introducingHPM
[17]. The study subjects were genotyped for 25 markers
covering 14Mb, including the HLA-region. There is a known
major susceptibility locus located in the center of the marker
map. The data consists of 385 affected sib-pairs and their
parents, out of which 100 randomly chosen families were
used.One childwas randomly selected fromeach family. The
nontransmitted parental haplotypes were used as controls
and the transmitted as cases.
6.2 Analysis of TreeDT
First, we assess the prediction accuracy of TreeDT with
different values of A, the proportion of disease-associated
chromosomes that actually carry the mutation (Fig. 6a). The
results are reported as curves that show the percentage of
100 data sets where the gene is within the predicted region,
as a function of the length of the predicted region. In other
words, the x-coordinate tells the cost a geneticist is willing
to pay, in terms of the length of the region to be further
analyzed, and the y-coordinate gives the probability that the
gene is within the region. For A ¼ 20% or 15% the accuracy
is very good and, with lower values of A, the accuracy
decreases until with A ¼ 5% only in 20-30 percent of data
sets can the gene be localized within a reasonable accuracy
of 10 cM. We remind the reader that the test settings have
been designed to be challenging, and to test the limits of the
approach.
Next, we evaluate the effect of the only parameter of
TreeDT, the number of mutation-carrying subtrees that are
searched for in each tree. An upper limit of kmax ¼ 3
subtrees, used in the previous test, is evaluated against
fixed numbers of one, two, or three subtrees, with a varying
number of founders that introduced the mutation (Fig. 6b).
As we increase the number of founders, evidence about the
gene location becomes more fragmented and, accordingly,
the performance degrades. While the differences between
different numbers of subtrees are not large, it is interesting
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to note that, for each number of founders, the same number
of subtrees gives marginally the best result. The upper limit
of three subtrees gives consistently competitive results, so
we continue using it in the following experiments.
As expected, the localization accuracy improves with
increasing sample size, although increasing the sample
sizes from 800 to 1,200 chromosomes does not significantly
improve the results any more (Fig. 6c). We also evaluated
the effect of the maximum number of subtrees in the
baseline setting, where there was a single mutation-carrying
founder. Decreasing the maximum number does improve
the accuracy, as shown in Fig. 6d, because the number of
tests on the lowest level decreases with it. However, tests
with different numbers of subtrees are highly correlated
and the differences in results are rather small. Furthermore,
the number of mutation-carrying founders for a real data
set is usually unknown, so it might not be wise to set too
low a limit.
In gene mapping studies like the ones simulated above, it
is assumed that a disease susceptibility gene is known to be
present in the analyzed area, based on a preliminary
analysis, e.g., by linkage analysis. TreeDT has the important
advantage over plain gene localization methods that it can
also be used to predict whether the analyzed region
contains a disease susceptibility gene at all or not. The
overall p value TreeDT produces indicates the corrected
statistical significance of the most significantly disease-
associated location and, by setting an upper limit for its
value, TreeDT can be used to classify data sets to ones that
do or do not contain a mutation. In order to verify the
correctness of the permutation procedure, we generated
100 data sets where the disease-association statuses were
randomly chosen for each individual, that is, there is no
genetic contribution from the simulated chromosome. For
these data sets, TreeDT should produce overall p values as
well as local p values from the uniform distribution in ½0; 1.
Fig. 7a shows the cumulative distribution of the observed
overall p values on these data sets; for only 100 data points,
the deviation from the diagonal is within expectations. The
10,200 local p values follow the uniform distribution very
convincingly (Fig. 7b).
Smaller thresholds for the overall p value result in fewer
false positives, but also in fewer true positives. Fig. 7c
shows the experimental relationship, in the form of an ROC
curve, between power (ratio true positives/all positives)
and overall p (ratio of false positives/all negatives). For
higher values of A, the classification accuracy is extremely
good. However, forA ¼ 5%, the power to detect the DS gene
is no better than random guessing, although the localization
accuracy for a gene known to exist is still adequate in 20-
30 percent of the cases (Fig. 6a).
6.3 Comparison to Other Methods
TreeDT, HPM, and m-TDT have practically identical
performance in localizing the DS gene in the baseline
setting (Fig. 8a). The parameters we used for HPM were
2-threshold 7, maximum pattern length 7, and one gap of at
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Fig. 6. Analysis of the performance of TreeDT. (a) Gene localization
accuracy with different values of A, the proportion of disease-associated
chromosomes that actually carry the mutation. (b) Gene localization
accuracy with different numbers of subtrees (parameter of the method,
given in the legend) and different numbers of founders (population
parameter: 1 for the highest set of curves, 2 for the curves in the middle,
and 3 for the lowest set of curves). (c) Gene localization accuracy with
different sample sizes. (d) Gene localization accuracy with different
maximum numbers of subtrees.
Fig. 7. (a) The cumulative distribution of overall p values on 100 data sets in which there were no DS genes. (b) The cumulative distribution of 10,200
local p values on the same data (pooled over all 102 tested locations per data set). (c) Statistical power to detect the existence of a disease
susceptibility gene.
most one marker. Single marker TDT is clearly inferior
compared to the other methods. Tests with other values of
A or other sample sizes give similar results (Appendix C,
which can be found on the Computer Society Digital
Library at http://computer.org/tcbb/archives.htm).
In a test setting with three founders who introduced the
mutation to the population, differences between the three
best methods start to appear (Fig. 8b). TreeDT has an edge
over HPM, which in turn performs better than m-TDT. TDT
barely beats random guessing.
Next, we compare the methods with a large amount of
missing data (Fig. 8c).We randomly removed 5 percent of the
alleles in the genotype data in family trios, adding further
complexity to the determination of parental origin. Conse-
quently, almost 15 percent of the allele information in the
resulting haplotypes is missing. Expectedly, HPM is most
robust with respect to missing data since it allows gaps in its
haplotypepatterns. Surprisingly, TreeDT is notmuchweaker
than HPM, although no actions have been taken in it to
account formissing or erroneous data: unlikeHPMandTDT,
TreeDT considers missing allele value as just another allele.
The performance of m-TDT degrades much more clearly as
the implementation in GENEHUNTER2 does not include
trios with missing alleles within a haplotype in the TDT
test for the haplotype. Using a simple method for
imputing values for the missing alleles improved the
results of TreeDT to be on a par with HPM (Appendix C,
which can be found on the Computer Society Digital
Library at http://computer.org/tcbb/archives.htm). We
were not able to run m-TDT on the imputed haplotypes
using GENEHUNTER2, but, in principle, a similar im-
provement should be seen.
With the SNP data of Lin et al., we compare TreeDT to
EATDT by the same authors and HPM. Because EATDT
only reports the location of the most significant haplotype,
we could only report the mapping performance as a
function of the localization error for the point estimate.
TreeDT and EATDT have equal performance up to ~700 kb
prediction error, HPM being slightly less accurate (Fig. 8d).
The result suggests that, with a reasonably dense marker
map, TreeDT performs well also with bi-allelic SNP data
and with data from general populations.
On the real Type 1 diabetes data, TreeDT pinpoints the
known DS locus very convincingly using 10,000 permuta-
tions (Fig. 8e). HPM with the same number of permutations
is able find the locus as well, but local p values given by
TreeDT are much smaller and the extrapolation mechanism
further highlights the predicted location. None of the
permutations gave at least as small a lowest local p value
as the lowest for the observed data. The overall corrected
p value is thus < 105.
The execution time of TreeDT for a simulated data setwith
400 haplotypes is about oneminute using 1,000 permutations
on a 1400MHz Pentium 4. The respective time for HPMwith
permutations is over 4 minutes.
7 DISCUSSION AND CONCLUSIONS
We have introduced TreeDT, a novel method for gene
mapping. It is based on genealogical analysis of haplotypes
and detects tree disequilibrium in the haplotype trees to the
right and left of the disease susceptibility gene location. We
have shown how tree disequilibrium can be efficiently
evaluated between every pair of consecutive markers and
SEVON ET AL.: TREEDT: TREE PATTERN MINING FOR GENE MAPPING 183
Fig. 8. Comparison of the gene localization accuracy of different methods. (a) The baseline test setting. (b) The baseline setting with three founders.
(c) The baseline setting with 15 percent missing data. (d) SNP data of Lin et al. (e) Comparison of TreeDT and HPM on real Type 1 diabetes data.
The known DS locus is denoted with a vertical line.
be subsequently tested for statistical significance using
multiple, nested permutation tests with the cost of one.
Nowadays, the focus of gene mapping methodology is
on complex diseases, where there are several genes and
possibly environmental factors contributing to susceptibil-
ity. With complex diseases, the associations of individual
genes are diluted by the effects of the other factors.
Therefore, methods looking for individual susceptibility
genes must be able to detect rather weak genetic effects.
Toward this end, in the simulated data sets used in the
experiments, only a small fraction (5-20 percent) of
chromosomes carried the mutated allele, creating a map-
ping challenge similar to that of mapping individual genes
for a complex disease.
One of the problems with real haplotype data is that
there are missing alleles due to problems in allele calling
and ambiguities in determination of the haplotypes. The
algorithm as applied in this paper regards a missing allele
as just another allele symbol. Although TreeDT does
reasonably well even with 15 percent of the alleles missing
in the haplotypes, we recommend that methods for
inferring the missing alleles [26], [28], [29] be applied to
the data prior to analysis, if possible.
Reconstruction of genealogies from haplotype data is a
difficult problem. In TreeDT, the use of haplotype trees to
estimate genealogical trees is based on the fact that the
expected length of the haplotype sharing decreases as the
time to the most recent common ancestor increases.
However, the length of haplotype sharing has large
variance and, consequently, the predictions of tree structure
are not very reliable. As a result, the mutation-carrying
subtree in the true genealogical tree may be split into a few
subtrees in the estimated tree. Or, on the other hand, it may
be merged with other subtrees, diluting the observable
disequilibrium in the combined subtree. The results from
our experiments suggest that, in most cases, the structure of
the estimated tree is close enough to that of the true
genealogical tree to allow for testing the disequilibrium
with good power.
The tree disequilibrium test itself is not bound to any
particular method for estimating the genealogical trees, so
more elaborate estimation techniques could be used. Also,
the test statistic for a given location (level 2) can be easily
modified to accommodate any number of genealogy
estimates for a location, e.g., a sample of estimates
produced by some stochastic method can be used.
Our experiments show that TreeDT is effective in
extreme conditions typical for current mapping projects:
with lots of noise (only 10-20 percent of affected chromo-
somes carry the mutation) and with small sample sizes (200
affected and 200 control chromosomes). We also showed a
successful mapping result using a real Type 1 diabetes data
set. However, the highest potential of the method lies with
data intensive tasks, such as genome-wide analyses with
larger samples and larger number of markers, due to its low
computational complexity.
While TreeDT was developed with isolated populations
in mind, we showed that, with a sufficiently dense marker
map, it can be effectively applied to data from general
populations as well. We compared TreeDT to two other
nonparametric methods suitable for analysis of genome-
wide data: HPM and TDT. TreeDT is most competitive,
especially in the presence of allelic heterogeneity. TreeDT
can also be used to predict whether a gene is present at all
or not. Unlike family-based association tests, such as TDT
and its variants, TreeDT can also be applied to case-control
samples of unrelated individuals for which haplotypes have
been inferred using population-based haplotyping methods
(e.g., [30], [31]). These features make it promising for
haplotype mapping from the first, genome-wide analyses to
more fine-grained analysis.
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